Original Research
Published on 16 Feb 2026
Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
in Hematologic Malignancies
- 273 views
Original Research
Published on 16 Feb 2026
in Hematologic Malignancies
Original Research
Published on 16 Feb 2026
in Pediatric Critical Care
Original Research
Published on 16 Feb 2026
in Digital Learning Innovations
Original Research
Published on 16 Feb 2026
in Neurodegeneration
Original Research
Published on 16 Feb 2026
in Phage Biology
Original Research
Published on 16 Feb 2026
in Computational Genomics
Original Research
Published on 16 Feb 2026
in Comparative Governance
Original Research
Published on 16 Feb 2026
in Inflammation
Original Research
Published on 16 Feb 2026
in Nutrition and Metabolism
Systematic Review
Published on 16 Feb 2026
in Public Health Education and Promotion
Original Research
Published on 16 Feb 2026
in Crop and Product Physiology
Review
Published on 16 Feb 2026
in Non-Apoptotic Regulated Cell Death
Case Report
Published on 16 Feb 2026
in Dermatology
Original Research
Published on 16 Feb 2026
in Urban Agriculture
Editorial
Published on 16 Feb 2026
in Quantum Information Theory
Editorial
Published on 16 Feb 2026
in Nutritional Immunology